nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—SLC22A7—Methotrexate—muscle cancer	0.133	0.162	CbGbCtD
Clarithromycin—CYP1A2—Dacarbazine—muscle cancer	0.0888	0.109	CbGbCtD
Clarithromycin—CYP3A7—Vincristine—muscle cancer	0.085	0.104	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.085	0.104	CbGbCtD
Clarithromycin—ABCB1—Dactinomycin—muscle cancer	0.0674	0.0823	CbGbCtD
Clarithromycin—CYP3A5—Vincristine—muscle cancer	0.0637	0.0779	CbGbCtD
Clarithromycin—CYP3A5—Etoposide—muscle cancer	0.0584	0.0714	CbGbCtD
Clarithromycin—CYP1A2—Etoposide—muscle cancer	0.0435	0.0531	CbGbCtD
Clarithromycin—ABCB1—Vincristine—muscle cancer	0.0415	0.0507	CbGbCtD
Clarithromycin—ABCB1—Etoposide—muscle cancer	0.038	0.0465	CbGbCtD
Clarithromycin—ABCB1—Doxorubicin—muscle cancer	0.0259	0.0317	CbGbCtD
Clarithromycin—ABCB1—Methotrexate—muscle cancer	0.0251	0.0307	CbGbCtD
Clarithromycin—CYP3A4—Vincristine—muscle cancer	0.0249	0.0304	CbGbCtD
Clarithromycin—CYP3A4—Etoposide—muscle cancer	0.0228	0.0278	CbGbCtD
Clarithromycin—CYP3A4—Doxorubicin—muscle cancer	0.0155	0.019	CbGbCtD
Clarithromycin—Vertigo—Etoposide—muscle cancer	0.000413	0.00227	CcSEcCtD
Clarithromycin—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000411	0.00226	CcSEcCtD
Clarithromycin—Leukopenia—Etoposide—muscle cancer	0.000411	0.00226	CcSEcCtD
Clarithromycin—Purpura—Doxorubicin—muscle cancer	0.00041	0.00226	CcSEcCtD
Clarithromycin—Abdominal pain—Dactinomycin—muscle cancer	0.000409	0.00225	CcSEcCtD
Clarithromycin—Body temperature increased—Dactinomycin—muscle cancer	0.000409	0.00225	CcSEcCtD
Clarithromycin—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000409	0.00225	CcSEcCtD
Clarithromycin—Hypoglycaemia—Doxorubicin—muscle cancer	0.000405	0.00223	CcSEcCtD
Clarithromycin—Loss of consciousness—Etoposide—muscle cancer	0.000404	0.00222	CcSEcCtD
Clarithromycin—Decreased appetite—Vincristine—muscle cancer	0.000402	0.00221	CcSEcCtD
Clarithromycin—Cough—Etoposide—muscle cancer	0.000401	0.0022	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Vincristine—muscle cancer	0.0004	0.0022	CcSEcCtD
Clarithromycin—Fatigue—Vincristine—muscle cancer	0.000399	0.00219	CcSEcCtD
Clarithromycin—Convulsion—Etoposide—muscle cancer	0.000398	0.00219	CcSEcCtD
Clarithromycin—Pain—Vincristine—muscle cancer	0.000396	0.00217	CcSEcCtD
Clarithromycin—Constipation—Vincristine—muscle cancer	0.000396	0.00217	CcSEcCtD
Clarithromycin—Asthma—Methotrexate—muscle cancer	0.000395	0.00217	CcSEcCtD
Clarithromycin—Chest pain—Etoposide—muscle cancer	0.000391	0.00215	CcSEcCtD
Clarithromycin—Eosinophilia—Methotrexate—muscle cancer	0.000391	0.00215	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000388	0.00213	CcSEcCtD
Clarithromycin—Pancreatitis—Methotrexate—muscle cancer	0.000387	0.00213	CcSEcCtD
Clarithromycin—Discomfort—Etoposide—muscle cancer	0.000386	0.00212	CcSEcCtD
Clarithromycin—Hypersensitivity—Dactinomycin—muscle cancer	0.000382	0.0021	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Vincristine—muscle cancer	0.000378	0.00208	CcSEcCtD
Clarithromycin—Confusional state—Etoposide—muscle cancer	0.000378	0.00208	CcSEcCtD
Clarithromycin—Cardiac arrest—Doxorubicin—muscle cancer	0.000376	0.00207	CcSEcCtD
Clarithromycin—Anaphylactic shock—Etoposide—muscle cancer	0.000375	0.00206	CcSEcCtD
Clarithromycin—Infection—Etoposide—muscle cancer	0.000372	0.00205	CcSEcCtD
Clarithromycin—Asthenia—Dactinomycin—muscle cancer	0.000372	0.00204	CcSEcCtD
Clarithromycin—Blood creatinine increased—Doxorubicin—muscle cancer	0.000371	0.00204	CcSEcCtD
Clarithromycin—Neutropenia—Methotrexate—muscle cancer	0.000369	0.00203	CcSEcCtD
Clarithromycin—Dysuria—Methotrexate—muscle cancer	0.000369	0.00203	CcSEcCtD
Clarithromycin—Thrombocytopenia—Etoposide—muscle cancer	0.000367	0.00202	CcSEcCtD
Clarithromycin—Abdominal pain—Vincristine—muscle cancer	0.000366	0.00201	CcSEcCtD
Clarithromycin—Body temperature increased—Vincristine—muscle cancer	0.000366	0.00201	CcSEcCtD
Clarithromycin—Liver function test abnormal—Doxorubicin—muscle cancer	0.000365	0.00201	CcSEcCtD
Clarithromycin—Skin disorder—Etoposide—muscle cancer	0.000364	0.002	CcSEcCtD
Clarithromycin—Hyperhidrosis—Etoposide—muscle cancer	0.000362	0.00199	CcSEcCtD
Clarithromycin—Breast disorder—Doxorubicin—muscle cancer	0.000357	0.00196	CcSEcCtD
Clarithromycin—Anorexia—Etoposide—muscle cancer	0.000357	0.00196	CcSEcCtD
Clarithromycin—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000356	0.00196	CcSEcCtD
Clarithromycin—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000356	0.00196	CcSEcCtD
Clarithromycin—Diarrhoea—Dactinomycin—muscle cancer	0.000354	0.00195	CcSEcCtD
Clarithromycin—Pneumonia—Methotrexate—muscle cancer	0.000354	0.00195	CcSEcCtD
Clarithromycin—Infestation NOS—Methotrexate—muscle cancer	0.000352	0.00193	CcSEcCtD
Clarithromycin—Infestation—Methotrexate—muscle cancer	0.000352	0.00193	CcSEcCtD
Clarithromycin—Depression—Methotrexate—muscle cancer	0.000351	0.00193	CcSEcCtD
Clarithromycin—Gastritis—Doxorubicin—muscle cancer	0.00035	0.00192	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000349	0.00192	CcSEcCtD
Clarithromycin—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000349	0.00192	CcSEcCtD
Clarithromycin—Renal failure—Methotrexate—muscle cancer	0.000346	0.0019	CcSEcCtD
Clarithromycin—Abdominal distension—Doxorubicin—muscle cancer	0.000344	0.00189	CcSEcCtD
Clarithromycin—Stomatitis—Methotrexate—muscle cancer	0.000343	0.00189	CcSEcCtD
Clarithromycin—Conjunctivitis—Methotrexate—muscle cancer	0.000342	0.00188	CcSEcCtD
Clarithromycin—Influenza—Doxorubicin—muscle cancer	0.000342	0.00188	CcSEcCtD
Clarithromycin—Asthma—Doxorubicin—muscle cancer	0.000342	0.00188	CcSEcCtD
Clarithromycin—Hypersensitivity—Vincristine—muscle cancer	0.000341	0.00187	CcSEcCtD
Clarithromycin—Eosinophilia—Doxorubicin—muscle cancer	0.000339	0.00186	CcSEcCtD
Clarithromycin—Paraesthesia—Etoposide—muscle cancer	0.000337	0.00185	CcSEcCtD
Clarithromycin—Haematuria—Methotrexate—muscle cancer	0.000336	0.00184	CcSEcCtD
Clarithromycin—Pancreatitis—Doxorubicin—muscle cancer	0.000335	0.00184	CcSEcCtD
Clarithromycin—Dyspnoea—Etoposide—muscle cancer	0.000334	0.00184	CcSEcCtD
Clarithromycin—Somnolence—Etoposide—muscle cancer	0.000333	0.00183	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Methotrexate—muscle cancer	0.000333	0.00183	CcSEcCtD
Clarithromycin—Epistaxis—Methotrexate—muscle cancer	0.000332	0.00183	CcSEcCtD
Clarithromycin—Asthenia—Vincristine—muscle cancer	0.000332	0.00182	CcSEcCtD
Clarithromycin—Vomiting—Dactinomycin—muscle cancer	0.000329	0.00181	CcSEcCtD
Clarithromycin—Agranulocytosis—Methotrexate—muscle cancer	0.000329	0.00181	CcSEcCtD
Clarithromycin—Rash—Dactinomycin—muscle cancer	0.000327	0.00179	CcSEcCtD
Clarithromycin—Decreased appetite—Etoposide—muscle cancer	0.000326	0.00179	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Etoposide—muscle cancer	0.000324	0.00178	CcSEcCtD
Clarithromycin—Fatigue—Etoposide—muscle cancer	0.000323	0.00178	CcSEcCtD
Clarithromycin—Pain—Etoposide—muscle cancer	0.000321	0.00176	CcSEcCtD
Clarithromycin—Constipation—Etoposide—muscle cancer	0.000321	0.00176	CcSEcCtD
Clarithromycin—Dysuria—Doxorubicin—muscle cancer	0.00032	0.00176	CcSEcCtD
Clarithromycin—Neutropenia—Doxorubicin—muscle cancer	0.00032	0.00176	CcSEcCtD
Clarithromycin—Haemoglobin—Methotrexate—muscle cancer	0.000318	0.00175	CcSEcCtD
Clarithromycin—Diarrhoea—Vincristine—muscle cancer	0.000317	0.00174	CcSEcCtD
Clarithromycin—Haemorrhage—Methotrexate—muscle cancer	0.000316	0.00174	CcSEcCtD
Clarithromycin—Hepatitis—Methotrexate—muscle cancer	0.000316	0.00174	CcSEcCtD
Clarithromycin—Pharyngitis—Methotrexate—muscle cancer	0.000314	0.00172	CcSEcCtD
Clarithromycin—Urinary tract disorder—Methotrexate—muscle cancer	0.000312	0.00172	CcSEcCtD
Clarithromycin—Urethral disorder—Methotrexate—muscle cancer	0.00031	0.0017	CcSEcCtD
Clarithromycin—Feeling abnormal—Etoposide—muscle cancer	0.000309	0.0017	CcSEcCtD
Clarithromycin—Nausea—Dactinomycin—muscle cancer	0.000308	0.00169	CcSEcCtD
Clarithromycin—Pneumonia—Doxorubicin—muscle cancer	0.000307	0.00169	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Etoposide—muscle cancer	0.000307	0.00168	CcSEcCtD
Clarithromycin—Dizziness—Vincristine—muscle cancer	0.000306	0.00168	CcSEcCtD
Clarithromycin—Infestation NOS—Doxorubicin—muscle cancer	0.000305	0.00168	CcSEcCtD
Clarithromycin—Infestation—Doxorubicin—muscle cancer	0.000305	0.00168	CcSEcCtD
Clarithromycin—Visual impairment—Methotrexate—muscle cancer	0.000305	0.00167	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000302	0.00166	CcSEcCtD
Clarithromycin—Renal failure—Doxorubicin—muscle cancer	0.0003	0.00165	CcSEcCtD
Clarithromycin—Erythema multiforme—Methotrexate—muscle cancer	0.000299	0.00164	CcSEcCtD
Clarithromycin—Urticaria—Etoposide—muscle cancer	0.000298	0.00164	CcSEcCtD
Clarithromycin—Stomatitis—Doxorubicin—muscle cancer	0.000297	0.00163	CcSEcCtD
Clarithromycin—Jaundice—Doxorubicin—muscle cancer	0.000297	0.00163	CcSEcCtD
Clarithromycin—Body temperature increased—Etoposide—muscle cancer	0.000296	0.00163	CcSEcCtD
Clarithromycin—Abdominal pain—Etoposide—muscle cancer	0.000296	0.00163	CcSEcCtD
Clarithromycin—Conjunctivitis—Doxorubicin—muscle cancer	0.000296	0.00163	CcSEcCtD
Clarithromycin—Eye disorder—Methotrexate—muscle cancer	0.000295	0.00162	CcSEcCtD
Clarithromycin—Tinnitus—Methotrexate—muscle cancer	0.000295	0.00162	CcSEcCtD
Clarithromycin—Vomiting—Vincristine—muscle cancer	0.000294	0.00162	CcSEcCtD
Clarithromycin—Cardiac disorder—Methotrexate—muscle cancer	0.000293	0.00161	CcSEcCtD
Clarithromycin—Rash—Vincristine—muscle cancer	0.000292	0.0016	CcSEcCtD
Clarithromycin—Dermatitis—Vincristine—muscle cancer	0.000292	0.0016	CcSEcCtD
Clarithromycin—Haematuria—Doxorubicin—muscle cancer	0.000291	0.0016	CcSEcCtD
Clarithromycin—Headache—Vincristine—muscle cancer	0.00029	0.00159	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000288	0.00158	CcSEcCtD
Clarithromycin—Epistaxis—Doxorubicin—muscle cancer	0.000288	0.00158	CcSEcCtD
Clarithromycin—Angiopathy—Methotrexate—muscle cancer	0.000287	0.00158	CcSEcCtD
Clarithromycin—Immune system disorder—Methotrexate—muscle cancer	0.000285	0.00157	CcSEcCtD
Clarithromycin—Mediastinal disorder—Methotrexate—muscle cancer	0.000285	0.00157	CcSEcCtD
Clarithromycin—Agranulocytosis—Doxorubicin—muscle cancer	0.000284	0.00156	CcSEcCtD
Clarithromycin—Chills—Methotrexate—muscle cancer	0.000284	0.00156	CcSEcCtD
Clarithromycin—Mental disorder—Methotrexate—muscle cancer	0.000277	0.00152	CcSEcCtD
Clarithromycin—Hypersensitivity—Etoposide—muscle cancer	0.000276	0.00152	CcSEcCtD
Clarithromycin—Malnutrition—Methotrexate—muscle cancer	0.000275	0.00151	CcSEcCtD
Clarithromycin—Haemoglobin—Doxorubicin—muscle cancer	0.000275	0.00151	CcSEcCtD
Clarithromycin—Nausea—Vincristine—muscle cancer	0.000275	0.00151	CcSEcCtD
Clarithromycin—Rhinitis—Doxorubicin—muscle cancer	0.000274	0.00151	CcSEcCtD
Clarithromycin—Haemorrhage—Doxorubicin—muscle cancer	0.000274	0.0015	CcSEcCtD
Clarithromycin—Hepatitis—Doxorubicin—muscle cancer	0.000274	0.0015	CcSEcCtD
Clarithromycin—Pharyngitis—Doxorubicin—muscle cancer	0.000272	0.00149	CcSEcCtD
Clarithromycin—Urinary tract disorder—Doxorubicin—muscle cancer	0.00027	0.00149	CcSEcCtD
Clarithromycin—Dysgeusia—Methotrexate—muscle cancer	0.000269	0.00148	CcSEcCtD
Clarithromycin—Asthenia—Etoposide—muscle cancer	0.000269	0.00148	CcSEcCtD
Clarithromycin—Connective tissue disorder—Doxorubicin—muscle cancer	0.000269	0.00148	CcSEcCtD
Clarithromycin—Urethral disorder—Doxorubicin—muscle cancer	0.000268	0.00147	CcSEcCtD
Clarithromycin—Back pain—Methotrexate—muscle cancer	0.000266	0.00146	CcSEcCtD
Clarithromycin—Pruritus—Etoposide—muscle cancer	0.000265	0.00146	CcSEcCtD
Clarithromycin—Visual impairment—Doxorubicin—muscle cancer	0.000264	0.00145	CcSEcCtD
Clarithromycin—Erythema multiforme—Doxorubicin—muscle cancer	0.000259	0.00142	CcSEcCtD
Clarithromycin—Diarrhoea—Etoposide—muscle cancer	0.000256	0.00141	CcSEcCtD
Clarithromycin—Eye disorder—Doxorubicin—muscle cancer	0.000256	0.00141	CcSEcCtD
Clarithromycin—Ill-defined disorder—Methotrexate—muscle cancer	0.000255	0.0014	CcSEcCtD
Clarithromycin—Tinnitus—Doxorubicin—muscle cancer	0.000255	0.0014	CcSEcCtD
Clarithromycin—Anaemia—Methotrexate—muscle cancer	0.000254	0.0014	CcSEcCtD
Clarithromycin—Cardiac disorder—Doxorubicin—muscle cancer	0.000254	0.0014	CcSEcCtD
Clarithromycin—Flushing—Doxorubicin—muscle cancer	0.000254	0.0014	CcSEcCtD
Clarithromycin—Angiopathy—Doxorubicin—muscle cancer	0.000248	0.00136	CcSEcCtD
Clarithromycin—Malaise—Methotrexate—muscle cancer	0.000248	0.00136	CcSEcCtD
Clarithromycin—Dizziness—Etoposide—muscle cancer	0.000248	0.00136	CcSEcCtD
Clarithromycin—Immune system disorder—Doxorubicin—muscle cancer	0.000247	0.00136	CcSEcCtD
Clarithromycin—Vertigo—Methotrexate—muscle cancer	0.000247	0.00136	CcSEcCtD
Clarithromycin—Mediastinal disorder—Doxorubicin—muscle cancer	0.000247	0.00136	CcSEcCtD
Clarithromycin—Leukopenia—Methotrexate—muscle cancer	0.000246	0.00135	CcSEcCtD
Clarithromycin—Chills—Doxorubicin—muscle cancer	0.000246	0.00135	CcSEcCtD
Clarithromycin—Cough—Methotrexate—muscle cancer	0.00024	0.00132	CcSEcCtD
Clarithromycin—Mental disorder—Doxorubicin—muscle cancer	0.00024	0.00132	CcSEcCtD
Clarithromycin—Convulsion—Methotrexate—muscle cancer	0.000238	0.00131	CcSEcCtD
Clarithromycin—Vomiting—Etoposide—muscle cancer	0.000238	0.00131	CcSEcCtD
Clarithromycin—Malnutrition—Doxorubicin—muscle cancer	0.000238	0.00131	CcSEcCtD
Clarithromycin—Rash—Etoposide—muscle cancer	0.000236	0.0013	CcSEcCtD
Clarithromycin—Dermatitis—Etoposide—muscle cancer	0.000236	0.0013	CcSEcCtD
Clarithromycin—Headache—Etoposide—muscle cancer	0.000235	0.00129	CcSEcCtD
Clarithromycin—Flatulence—Doxorubicin—muscle cancer	0.000235	0.00129	CcSEcCtD
Clarithromycin—Myalgia—Methotrexate—muscle cancer	0.000234	0.00129	CcSEcCtD
Clarithromycin—Chest pain—Methotrexate—muscle cancer	0.000234	0.00129	CcSEcCtD
Clarithromycin—Tension—Doxorubicin—muscle cancer	0.000234	0.00128	CcSEcCtD
Clarithromycin—Dysgeusia—Doxorubicin—muscle cancer	0.000233	0.00128	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000233	0.00128	CcSEcCtD
Clarithromycin—Discomfort—Methotrexate—muscle cancer	0.000231	0.00127	CcSEcCtD
Clarithromycin—Nervousness—Doxorubicin—muscle cancer	0.000231	0.00127	CcSEcCtD
Clarithromycin—Back pain—Doxorubicin—muscle cancer	0.00023	0.00127	CcSEcCtD
Clarithromycin—Muscle spasms—Doxorubicin—muscle cancer	0.000229	0.00126	CcSEcCtD
Clarithromycin—Confusional state—Methotrexate—muscle cancer	0.000226	0.00124	CcSEcCtD
Clarithromycin—Anaphylactic shock—Methotrexate—muscle cancer	0.000225	0.00123	CcSEcCtD
Clarithromycin—Infection—Methotrexate—muscle cancer	0.000223	0.00123	CcSEcCtD
Clarithromycin—Nausea—Etoposide—muscle cancer	0.000223	0.00122	CcSEcCtD
Clarithromycin—Ill-defined disorder—Doxorubicin—muscle cancer	0.000221	0.00121	CcSEcCtD
Clarithromycin—Nervous system disorder—Methotrexate—muscle cancer	0.00022	0.00121	CcSEcCtD
Clarithromycin—Anaemia—Doxorubicin—muscle cancer	0.00022	0.00121	CcSEcCtD
Clarithromycin—Thrombocytopenia—Methotrexate—muscle cancer	0.00022	0.00121	CcSEcCtD
Clarithromycin—Agitation—Doxorubicin—muscle cancer	0.000219	0.0012	CcSEcCtD
Clarithromycin—Skin disorder—Methotrexate—muscle cancer	0.000218	0.0012	CcSEcCtD
Clarithromycin—Hyperhidrosis—Methotrexate—muscle cancer	0.000217	0.00119	CcSEcCtD
Clarithromycin—Malaise—Doxorubicin—muscle cancer	0.000215	0.00118	CcSEcCtD
Clarithromycin—Vertigo—Doxorubicin—muscle cancer	0.000214	0.00118	CcSEcCtD
Clarithromycin—Anorexia—Methotrexate—muscle cancer	0.000214	0.00118	CcSEcCtD
Clarithromycin—Leukopenia—Doxorubicin—muscle cancer	0.000213	0.00117	CcSEcCtD
Clarithromycin—Palpitations—Doxorubicin—muscle cancer	0.000211	0.00116	CcSEcCtD
Clarithromycin—Loss of consciousness—Doxorubicin—muscle cancer	0.000209	0.00115	CcSEcCtD
Clarithromycin—Cough—Doxorubicin—muscle cancer	0.000208	0.00114	CcSEcCtD
Clarithromycin—Convulsion—Doxorubicin—muscle cancer	0.000206	0.00113	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000205	0.00112	CcSEcCtD
Clarithromycin—Insomnia—Methotrexate—muscle cancer	0.000203	0.00112	CcSEcCtD
Clarithromycin—Chest pain—Doxorubicin—muscle cancer	0.000203	0.00111	CcSEcCtD
Clarithromycin—Myalgia—Doxorubicin—muscle cancer	0.000203	0.00111	CcSEcCtD
Clarithromycin—Anxiety—Doxorubicin—muscle cancer	0.000202	0.00111	CcSEcCtD
Clarithromycin—Paraesthesia—Methotrexate—muscle cancer	0.000202	0.00111	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000201	0.00111	CcSEcCtD
Clarithromycin—Discomfort—Doxorubicin—muscle cancer	0.0002	0.0011	CcSEcCtD
Clarithromycin—Dyspnoea—Methotrexate—muscle cancer	0.0002	0.0011	CcSEcCtD
Clarithromycin—Somnolence—Methotrexate—muscle cancer	0.0002	0.0011	CcSEcCtD
Clarithromycin—Dry mouth—Doxorubicin—muscle cancer	0.000198	0.00109	CcSEcCtD
Clarithromycin—Dyspepsia—Methotrexate—muscle cancer	0.000198	0.00109	CcSEcCtD
Clarithromycin—Confusional state—Doxorubicin—muscle cancer	0.000196	0.00108	CcSEcCtD
Clarithromycin—Decreased appetite—Methotrexate—muscle cancer	0.000195	0.00107	CcSEcCtD
Clarithromycin—Anaphylactic shock—Doxorubicin—muscle cancer	0.000194	0.00107	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000194	0.00107	CcSEcCtD
Clarithromycin—Fatigue—Methotrexate—muscle cancer	0.000194	0.00106	CcSEcCtD
Clarithromycin—Infection—Doxorubicin—muscle cancer	0.000193	0.00106	CcSEcCtD
Clarithromycin—Pain—Methotrexate—muscle cancer	0.000192	0.00106	CcSEcCtD
Clarithromycin—Nervous system disorder—Doxorubicin—muscle cancer	0.000191	0.00105	CcSEcCtD
Clarithromycin—Thrombocytopenia—Doxorubicin—muscle cancer	0.00019	0.00105	CcSEcCtD
Clarithromycin—Skin disorder—Doxorubicin—muscle cancer	0.000189	0.00104	CcSEcCtD
Clarithromycin—Hyperhidrosis—Doxorubicin—muscle cancer	0.000188	0.00103	CcSEcCtD
Clarithromycin—Anorexia—Doxorubicin—muscle cancer	0.000185	0.00102	CcSEcCtD
Clarithromycin—Feeling abnormal—Methotrexate—muscle cancer	0.000185	0.00102	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Methotrexate—muscle cancer	0.000184	0.00101	CcSEcCtD
Clarithromycin—Urticaria—Methotrexate—muscle cancer	0.000178	0.00098	CcSEcCtD
Clarithromycin—Abdominal pain—Methotrexate—muscle cancer	0.000178	0.000976	CcSEcCtD
Clarithromycin—Body temperature increased—Methotrexate—muscle cancer	0.000178	0.000976	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000177	0.000974	CcSEcCtD
Clarithromycin—Insomnia—Doxorubicin—muscle cancer	0.000176	0.000966	CcSEcCtD
Clarithromycin—Paraesthesia—Doxorubicin—muscle cancer	0.000175	0.00096	CcSEcCtD
Clarithromycin—Dyspnoea—Doxorubicin—muscle cancer	0.000173	0.000953	CcSEcCtD
Clarithromycin—Somnolence—Doxorubicin—muscle cancer	0.000173	0.00095	CcSEcCtD
Clarithromycin—Dyspepsia—Doxorubicin—muscle cancer	0.000171	0.000941	CcSEcCtD
Clarithromycin—Decreased appetite—Doxorubicin—muscle cancer	0.000169	0.000929	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000168	0.000923	CcSEcCtD
Clarithromycin—Fatigue—Doxorubicin—muscle cancer	0.000168	0.000921	CcSEcCtD
Clarithromycin—Pain—Doxorubicin—muscle cancer	0.000166	0.000914	CcSEcCtD
Clarithromycin—Constipation—Doxorubicin—muscle cancer	0.000166	0.000914	CcSEcCtD
Clarithromycin—Hypersensitivity—Methotrexate—muscle cancer	0.000165	0.000909	CcSEcCtD
Clarithromycin—Asthenia—Methotrexate—muscle cancer	0.000161	0.000885	CcSEcCtD
Clarithromycin—Feeling abnormal—Doxorubicin—muscle cancer	0.00016	0.000881	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000159	0.000874	CcSEcCtD
Clarithromycin—Pruritus—Methotrexate—muscle cancer	0.000159	0.000873	CcSEcCtD
Clarithromycin—Urticaria—Doxorubicin—muscle cancer	0.000154	0.000849	CcSEcCtD
Clarithromycin—Abdominal pain—Doxorubicin—muscle cancer	0.000154	0.000845	CcSEcCtD
Clarithromycin—Body temperature increased—Doxorubicin—muscle cancer	0.000154	0.000845	CcSEcCtD
Clarithromycin—Diarrhoea—Methotrexate—muscle cancer	0.000154	0.000844	CcSEcCtD
Clarithromycin—Dizziness—Methotrexate—muscle cancer	0.000148	0.000816	CcSEcCtD
Clarithromycin—Hypersensitivity—Doxorubicin—muscle cancer	0.000143	0.000787	CcSEcCtD
Clarithromycin—Vomiting—Methotrexate—muscle cancer	0.000143	0.000785	CcSEcCtD
Clarithromycin—Rash—Methotrexate—muscle cancer	0.000142	0.000778	CcSEcCtD
Clarithromycin—Dermatitis—Methotrexate—muscle cancer	0.000141	0.000777	CcSEcCtD
Clarithromycin—Headache—Methotrexate—muscle cancer	0.000141	0.000773	CcSEcCtD
Clarithromycin—Asthenia—Doxorubicin—muscle cancer	0.000139	0.000767	CcSEcCtD
Clarithromycin—Pruritus—Doxorubicin—muscle cancer	0.000138	0.000756	CcSEcCtD
Clarithromycin—Nausea—Methotrexate—muscle cancer	0.000133	0.000733	CcSEcCtD
Clarithromycin—Diarrhoea—Doxorubicin—muscle cancer	0.000133	0.000731	CcSEcCtD
Clarithromycin—Dizziness—Doxorubicin—muscle cancer	0.000129	0.000707	CcSEcCtD
Clarithromycin—Vomiting—Doxorubicin—muscle cancer	0.000124	0.000679	CcSEcCtD
Clarithromycin—Rash—Doxorubicin—muscle cancer	0.000123	0.000674	CcSEcCtD
Clarithromycin—Dermatitis—Doxorubicin—muscle cancer	0.000122	0.000673	CcSEcCtD
Clarithromycin—Headache—Doxorubicin—muscle cancer	0.000122	0.000669	CcSEcCtD
Clarithromycin—Nausea—Doxorubicin—muscle cancer	0.000115	0.000635	CcSEcCtD
